Trial site
Finlay Medical Research
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Chronic spontaneous urticaria3 trials
- COPD1 trial
- Phase
- Phase 311 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed6 trials
- Active, not recruiting5 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company5 trials
- Novartis Pharmaceuticals3 trials
- BioNTech SE2 trials
- Ionis Pharmaceuticals, Inc.2 trials
- Pfizer1 trial
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- COPD1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026